VEGFA and Coats disease: Alsaggaf et al. reported the efficacy of Aflibercept intravitreal injection in adult-onset Coats’ disease patients, and, based on literature, established that aflibercept is more effective than other anti-VEGF, as the former targets both VEGF and the placental growth factor [31,32].